ArticleCells2026

Developing a Phosphodiesterase 10A Inhibitor as a Novel Therapeutic Agent for Triple-Negative Breast Cancer.

Mrityunjoy Biswas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.